Francis DupontHead of Technology at Novasep, Brussels
In 1993 at Brussels University, Francis Dupont earned a PhD in molecular virology, focused on cancer-targeted gene therapy. He conducted a post-doc in applied research in vectorology, viral vectors process development and cancer-targeted gene therapy. In 2000, he integrated Novasep Belgium as Project Manager and became Head of R&D in 2011. Since early 2014, Francis has been named Head of Technology as an expert on viral vectors and vectorized vaccine manufacturing.